Lyell Immunopharma Inc.

LYEL

Held by 1 specialist biotech fund

Share on X

Fund Holdings

OrbiMed Advisors

Position history (shares)

OrbiMed Advisors

2Q

2 quarters

Position Trend

Aug 14, 2025

$457K

1 fund

Nov 14, 2025

$840K

1 fund

Feb 17, 2026

$0

0 funds

-100% total institutional value over 3 quarters

Short Interest

Short Shares

940K

Change

+58.8%

Days to Cover

9.5

% of Float

4.8%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Position Details

OrbiMed AdvisorsEXITFeb 17, 2026

Shares: 51,727Value: $840K

OrbiMed AdvisorsINCREASENov 14, 2025

Shares: 51,727Value: $840K

+ 1more — see how much conviction went in

See the Full Story

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

APLS1 fund RNA1 fund ARGX1 fund PRAX1 fund CTMX1 fund ACET1 fund PTCT1 fund CAI1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: